Hardy Diagnostic Reagents and Supplies
ID: NIH-CC-OPC-25-002025Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/acea65568342451095dd46c287941e8c/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to Hardy Diagnostics for the procurement of culture media and organism supplies necessary for cGMP Sterility Testing Services. The primary objective is to ensure compliance with FDA regulations by utilizing cGMP quality materials that have been rigorously validated, as these supplies are critical for the isolation and identification of pathogens affecting critically ill patients. The contract will cover a base period of twelve months with an option for an additional three months, and interested vendors capable of providing similar products are encouraged to submit capability statements by the specified deadline. For further inquiries, potential respondents may contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.

    Point(s) of Contact
    Kimala Winfield
    (301) 496-7015
    kimala.winfield@nih.gov
    Malinda Dehner
    (301) 594-6320
    dehnerm@cc.nih.gov
    Files
    Title
    Posted
    Supply List 25-002025.pdf
    The document titled "Supply List 25-002025" outlines requirements for a government solicitation concerning supplies needed for various federal and local projects. The list specifies the types of materials and products essential for meeting project objectives, detailing quantities and specifications that comply with government standards. It serves as part of Requests for Proposals (RFPs) aimed at both federal grants and state/local needs, facilitating vendors in preparing their bids to fulfill the supply requirements effectively. The main focus is on ensuring that all procured items adhere to the strict guidelines of quality and performance that are mandated by governmental regulations. This supply list is instrumental in guiding procurement processes and fostering transparency and accountability in government spending. Overall, it plays a vital role in streamlining the bidding process for suppliers participating in governmental contracts, ensuring that all aspects are covered for operational efficiency.
    Lifecycle
    Title
    Type
    Hardy Diagnostic Reagents and Supplies
    Currently viewing
    Presolicitation
    Similar Opportunities
    CHROMIUM GEM-X SINGLE CELL 5’ KIT REAGENTS
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of CHROMIUM GEM-X SINGLE CELL 5’ KIT REAGENTS to support ongoing clinical trials focused on B cell responses to vaccine products. This acquisition involves the purchase of 10X Genomics reagents, which are critical for analyzing immune responses in the context of infectious and autoimmune diseases. The selected contractor will be required to deliver the reagents to the NIH facility in Bethesda, Maryland, as soon as possible after award, with quotes due by July 21, 2025, at 10:00 AM EST. Interested vendors should direct inquiries to Rita Davis at rita.davis@nih.gov and ensure their submissions include the RFQ number in the subject line.
    Laboratory Supplies and Reagents
    Buyer not available
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information from U.S. vendors regarding domestically manufactured laboratory supplies and reagents compatible with the Sartorius AMBR 250 Automated Mammalian Bio Reactor system. This Sources Sought notice emphasizes compliance with the Buy American Act and Executive Order 14005, requiring respondents to certify that their products are manufactured in the United States. The consumables are critical for research and development within the field of infectious diseases, and interested vendors must submit their capability statements through the NIAID electronic Simplified Acquisition Submission System (eSASS) by July 21, 2025. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse Weidow at weidowjd@niaid.nih.gov.
    CDC DFWED NARST Sensititre Supplies
    Buyer not available
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    Acquisition of Services for cGMP Testing of PEN-866 Drug Conjugate
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure services for the generation of a new Certificate of Analysis (CoA) for the drug conjugate PEN-866, which is critical for ongoing clinical trials involving pediatric and young adult cancer patients. The selected contractor will be responsible for conducting comprehensive testing and analysis under strict Current Good Manufacturing Practice (cGMP) regulations, ensuring the drug's stability and compliance throughout the trial period. PEN-866 is an important HSP90 inhibitor-drug-conjugate that has shown promise in tumor regression and survival improvement in various pediatric sarcoma models. Interested parties must submit their capability statements or proposals to Contracting Officer John Russell at John.Russell3@nih.gov by 10:00 A.M. EST on July 18, 2025, referencing notice number 75N91025Q00045. This acquisition will be processed as a sole source contract with PPD Development LP, the only vendor with established testing protocols for PEN-866.
    Maintenance Service for Illumina NextSeq™ 2000 Sequencer
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a Firm-Fixed price purchase order for maintenance services on the Illumina NextSeq™ 2000 Sequencer, which is critical for diagnosing inherited immune disorders within the Department of Lab Medicine. The procurement will cover comprehensive support, including parts, labor, travel, and technical assistance, with the requirement that only Illumina, Inc. can provide the necessary services due to their exclusive access to performance-verified components and technical expertise. Interested parties capable of offering similar services are invited to submit a capability statement by the specified deadline, with all inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.
    AGILENT TECHNOLOGIES, INC 5200 FRAGENT ANALYER INSTRUMENT, AND COMPUTER AND MONITOR
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure an Agilent Technologies, Inc 5200 Fragment Analyzer Instrument, along with a computer and monitor, on a sole source basis. This acquisition aims to replace the discontinued Agilent 2100 Bioanalyzer, providing enhanced performance, scalability, and workflow efficiency for the Department of Transfusion Medicine (DTM). The new system is critical for accurate assessment of DNA, RNA, and NGS library preparations, which are essential for ongoing research studies. Interested parties capable of providing similar products may submit a capability statement to Emeka Onyejekwe at emeka.onyejekwe@nih.gov by July 19, 2025, at noon EST for consideration.
    DNA PROBE LABELING AND MICROARRAYS KITS
    Buyer not available
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is announcing a pre-solicitation notice for the procurement of DNA probe labeling and microarrays kits, intending to negotiate a sole-source contract with Agilent Technologies Inc. The required items include various specialized kits such as the Unrestricted AMADID Release GE 4x44K and LowInput QuickAmp Labeling Kit, which are critical for NIAID's research and operational needs. This procurement is justified under the statutory authority that only Agilent can provide the necessary components, emphasizing the importance of these specialized goods in supporting the agency's mission. Interested vendors may submit capability statements along with authorization letters from Agilent by July 21, 2025, at noon EST, through the NIAID e-BidBoard System, with all submissions subject to the outlined procedural requirements.
    Notice of Intent to Sole Source – Cardinal Health, Inc.
    Buyer not available
    The National Institutes of Health (NIH) intends to award a fixed-price purchase order to Cardinal Health, Inc. for the procurement of Floxuridine Vials, specifically for patient care at the NIH Clinical Center in Maryland. The requirement includes 10 units of Floxuridine for Injection, catalog number 0143-9270-01, which is critical for patient treatment and is exclusively distributed by Cardinal Health, Inc. This acquisition will be conducted under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole source award due to the unique availability of the medication. Interested parties may submit their comments or expressions of interest to Kristin Nagashima at kristin.nagashima@nih.gov by July 18, 2025, at 9 AM EST.
    Notice of Intent for Simple Plex Cartridge Kits for the ELLA Instrument
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is issuing a presolicitation notice for the procurement of Simple Plex Cartridge Kits for the ELLA Instrument. The NIH intends to award a firm fixed price Purchase Order on a sole source basis to Cyvek Inc., the sole provider of these kits, which are essential for studying protein biomarkers in various biological samples. The Simple Plex Cartridge Kits are critical for ensuring accurate testing results and maintaining the integrity of ongoing research, as they are the only compatible products for the ELLA Instrument. Interested parties capable of providing similar products may submit a capability statement by July 20, 2025, to Tasha Lowe at lowet2@mail.nih.gov.
    Inverted All-in-One Fluorescence Microscope
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) NIDA, is seeking potential suppliers for an Inverted All-in-One Fluorescence Microscope through a Sources Sought notice. The procurement aims to identify qualified companies capable of providing a microscope that facilitates high-speed imaging and accommodates multi-well plates or flasks, featuring essential technical specifications such as a built-in vibration dampening system, motorized stages, and advanced imaging capabilities. This equipment is crucial for the NIDA Histology and Imaging Core's research activities, emphasizing the need for high-resolution imaging and sophisticated analysis software. Interested vendors must submit documentation of their capabilities, including business size status under NAICS code 334516, by July 27, 2025, to the primary contact, Polina Klimenkova, at polina.klimenkova@nih.gov.